About TTY Biopharm
TTY Biopharm is a publicly listed company based in Taipei (Taiwan) founded in 1960. Anti-cancer, anti-infection, and vaccine products are developed and manufactured. Its website tty.com.tw draws about 11 thousand monthly visits. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified.
Company details
TTY Biopharm was founded in 1960 and is based in Taipei, Taiwan. Operations focus on the biopharmaceutical sector, with major technology platforms centered on liposome and microsphere systems. Conventional products encompass oral dosage forms such as immediate-release and sustained-release drugs, liquid injections, ointments, and gels. Services provided include formulation development, analytical development, process development, and animal studies.
- Headquarters Taipei, Taiwan
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website tty.com.tw
- Social LinkedIn Facebook
- Legal Name Tty Biopharm Company Limited
- Annual Revenue$6.45 B9.46as on Dec 31, 2025
- Net Profit$1.56 B7.55as on Dec 31, 2025
- EBITDA$1.9 B19.07as on Dec 31, 2025
IPO & Listings of TTY Biopharm
TTY Biopharm is a publicly listed company on the TPEX with ticker symbol 4105 in Taiwan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date27 Sep 2001
- Listed onTT: 4105
- Listed entityTTY Biopharm Company Limited
- Exchange sectorHealth technology
- ISINTW0004105002
- Share price81.80 TWD (-0.37% on the day) · 2026-10-14
- Market capitalisation20,414,160,361.00 TWD
- Price to earnings11.8
- EPS (diluted, trailing year)6.96 TWD
- Dividend yield5.5%
- Volume (last session)723,990
Financials of TTY Biopharm
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 6.45B TWD | 1.56B TWD | 1.90B TWD |
| 2024 | 5.90B TWD | 1.45B TWD | 1.60B TWD |
| 2023 | 5.50B TWD | 1.13B TWD | 1.57B TWD |
| 2022 | 5.06B TWD | 1.09B TWD | 1.41B TWD |
| 2021 | 4.53B TWD | 831.9M TWD | 1.31B TWD |
Detailed financial statements for TTY Biopharm
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of TTY Biopharm
The website of TTY Biopharm (tty.com.tw) receives about 10.6K visits a month and ranks #1,615,209 among all websites worldwide, #2,173 in Biotechnology and Pharmaceuticals.
- Monthly visits10.6K
▼ 16.4% vs previous month
- Unique visitors4.8K
per month
- Global rank#1,615,209
among all websites
- Category rank#2,173
Health · Biotechnology and Pharmaceuticals
- Bounce rate51%
- Pages per visit2.7
- Average visit55 sec
- DevicesDesktop 42% · Mobile 58%
Websites whose visitors overlap most with TTY Biopharm. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| yashpharma.com | 100% | View details | |||
janssenpharmaceutica.be | janssenpharmaceutica.be | 100% | – | ||
farma-tek.com | farma-tek.com | 100% | #3,152,871 | – | |
| bayer.com | 100% | 1.1M | #52,188 | View details | |
| lavoisier.com | 100% | #2,882,237 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 27 similar websites and full traffic analytics for TTY Biopharm
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 27 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Tty Biopharm
Complete news archive for TTY Biopharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TTY Biopharm
TTY Biopharm was founded in 1960.
TTY Biopharm is headquartered in Taipei, Taiwan.
TTY Biopharm was founded in 1960 and is based in Taipei, Taiwan. Operations focus on the biopharmaceutical sector, with major technology platforms centered on liposome and microsphere systems. Conventional products encompass oral dosage forms such as immediate-release and sustained-release drugs, liquid injections, ointments, and gels. Services provided include formulation development, analytical development, process development, and animal studies.
Yes, TTY Biopharm is publicly traded on TPEX under the ticker symbol 4105.